| Molecular formula | C192H289N47O61 |
|---|
| Molecular weight | 4232 g/mol |
|---|
| Registered trials | 26 |
|---|
| PubChem CID | 171378821 |
|---|
What survodutide is
Survodutide is a peptide compound (molecular formula C192H289N47O61) identified in chemical databases under PubChem CID 171378821. It is currently classified as an investigational agent, meaning it has no approved prescribing label, approved indication, or established brand name. Any information about it comes from clinical trial records rather than an approved drug label.
Trial footprint
Survodutide has 26 registered clinical trials. Sampled studies include early-phase work such as a completed trial examining how the compound (referenced under the code BI 456906) is taken up in the blood of people with and without kidney problems, and a completed trial in healthy participants comparing two different formulations. Another sampled trial, currently active but not recruiting, is studying whether survodutide affects how the body uses energy and breaks down fat in people with obesity. These trials reflect ongoing research activity and do not establish that the compound is safe or effective for any use.
FAQ
No. Survodutide is an investigational compound with no approved label, indication, or brand name. All available information comes from clinical trial records rather than an approved drug label.
Survodutide is a peptide with the molecular formula C192H289N47O61. It is cataloged in chemical databases under PubChem CID 171378821.
There are 26 registered clinical trials involving survodutide. Sampled studies span early-phase pharmacokinetic research and studies looking at energy and fat metabolism in people with obesity.
Sampled trials have examined how the compound is absorbed in people with kidney problems, compared different formulations in healthy volunteers, and assessed effects on energy use and fat breakdown in people with obesity. These studies do not confirm safety or effectiveness for any condition.
No brand name is available because survodutide has not received regulatory approval. It is referenced in research settings by its compound name and, in some trial records, by the code BI 456906.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem ClinicalTrials.gov
Updated 2026-09-19